PhD dissertations

​List of dissertations from CCIT


Aishwarya Gokuldass: Profiling cross-talk between tumour cells and tumour-infiltrating lymphocytes (TILs)

Julie Westerlin Kjeldsen: Immune modulatory vaccines targeting IDO and PD-L1 in solid tumours

Anders Handrup Kverneland: Adoptive cell therapy across cancer diagnoses.

Ana Micaela Carnaz Simões: Systemic Immune Suppression in Cancer: The Opposing Roles of Platelets and Exercise


Simone Kloch Bendtsen: Exploring New Targets for Immunotherapy in Cancer

Christina Friese: Characterization of tumor-infiltrating lymphocytes after checkpoint blockade within the tumor microenvironment of tumor fragments 


Marie Christine Wulf Westergaard: Characterization of tumor-infiltrating lymphocytes and the tumor microenvironment in patients with ovarian cancer 

Sara Ram Pedersen, MSc: Characterization of immunoregulatory mechanisms in the tumor microenvironment

Morten Nielsen, MD: In vitro expansion of tumour-infiltrating lymphocytes from sarcoma

Dorota Ewa Kuczek, MSc: The immunomodulatory effects of the extracellular matrix

Magnus Pedersen, MD: Adoptive Cell Therapy Regimens with Tumor-Infiltrating Lymphocytes in Ovarian Cancer and Renal Cell Carcinoma


​Evelina Martinenaite, MSc.: Preventing immune inhibition in cancer: characterization of immune responses against immune regulatory proteins

Gitte Holmen Olofsson, MSc.: Vγ9Vδ2 T cells as cancer cell killers and antigen presenting cells

Troels Holz Borch, MD: Evaluation of immune responses to dendritic cell vaccination and adoptive cell therapy


Morten Orebo Holmström, MD: Targeting the Shared Neoantigens: Potentials of Cancer Immune Therapy in Chronic

Rikke Andersen, MD: Exploiting tumor-infiltrating lymphocytes for the treatment of cancer

Manja Idorn, MSc.: Genetic Engineering of T cells for Improved Homing to Tumor Site - Optimizing Adoptive Cell Therapy

Shamaila Munir Ahmad, cand.scient.: T-cell responses against PD-L1 protein in cancer patients.

Per Kongsted, MD: Taxane-based chemotherapy and dendritic cell therapy in metastatic castration-resistant prostate cancer.


Jon Bjørn, MD: Ipilimumab in the treatment of metastatic malignant melanoma. Immunological correlates of treatment and combination therapy.


Thomas Mørch Frøsig, cand.scient.pharm.: Elucidating the immunological effects of 5-Azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.

Caroline Hasselbalch Riley, MD.: Immunological phenotype in patients with JAK2 V617F-positive chronic myeloproliferative neoplasms. Impact of immune therapy with IFN-alpha.

Mads Duus Hjortsø, cand.scient.: T-cell Recognition of Immune Modulatory Molecules in Cancer

Stine Kiær Larsen, cand. scient.Cellular Immune Responses Towards Regulatory Cells


Marco Donia, MD: Methods to improve Adoptive T cell therapy with tumor infiltrating lymphocytes

Rikke Sick Andersen, cand. scient.Dissection of human melanoma specific T-cell immunity by use of combinatorial encoding MHC multimers

Trine Zeeberg Iversen, MD: Immune Modulations during Chemo-Immunotherapy & Novel Vaccine Strategies - In Metastatic Melanoma and Non Small-Cell Lung Cancer


Tania Køllgaard, cand. scient.Immune regulatory cells and polymorphisms in cancer

Eva Ellebæk, MD: Dendritic cell vaccination and adoptive cell therapy in patients with metastatic malignant melanoma

Anne Ortved Gang, MD: Immune modulatory effects of azacytidine and possible implications for immunotherapy


Lotte Engell-Nørregård, MD: Dendritic cell vaccination of patients with metastatic malignant melanoma​

Niels Junker, MD: Ex vivo expansion and characterization of tumor infiltrating lymphocyte derived T effector memory cells from malignant melanoma and oral squamous cell carcinoma